Tensopyn Effervescent נמיביה - אנגלית - Namibia Medicines Regulatory Council

tensopyn effervescent

mirren (sa) (pty) ltd - caffeine; codeine phosphate; doxylamine succinate; paracetamol - tablet - each tablet contains paracetamol 450 mg, ; doxylamine succinate 5 mg, caffeine ; anhydrous 50 mg and codeine phosphate ; 10 m

CIPLA PAIN RELIEF PARACETAMOL + CODEINE with CALMATIVE tablet blister pack אוסטרליה - אנגלית - Department of Health (Therapeutic Goods Administration)

cipla pain relief paracetamol + codeine with calmative tablet blister pack

cipla australia pty ltd - doxylamine succinate, quantity: 5.1 mg; codeine phosphate hemihydrate, quantity: 10 mg; paracetamol, quantity: 500 mg - tablet, uncoated - excipient ingredients: maize starch; povidone; purified talc; magnesium stearate; pregelatinised maize starch; sodium lauryl sulfate; colloidal anhydrous silica; hyprolose; stearic acid - for the temporary relief of acute moderate pain

VITAPYN Tablet קניה - אנגלית - Pharmacy and Poisons Board

vitapyn tablet

eastleigh pharmaceuticals co. ltd eastleigh 2nd avenue, 14th street p.o box - paracetamol, codeine phosphate, doxylamine… - tablet - paracetamol bp 450 mg, codeine phosphate bp 10… - paracetamol combinations excl. psycholeptics

Painex caplets הממלכה המאוחדת - אנגלית - MHRA (Medicines & Healthcare Products Regulatory Agency)

painex caplets

sandoz ltd - paracetamol; codeine phosphate; doxylamine succinate; caffeine - tablet - 450mg ; 10mg ; 5mg ; 30mg

Syndol caplets הממלכה המאוחדת - אנגלית - MHRA (Medicines & Healthcare Products Regulatory Agency)

syndol caplets

ssl international plc - paracetamol; codeine phosphate; doxylamine succinate; caffeine - tablet - 450mg ; 10mg ; 5mg ; 30mg

SYNDOL Tablets 450/10/5/3 Milligram אירלנד - אנגלית - HPRA (Health Products Regulatory Authority)

syndol tablets 450/10/5/3 milligram

g & a licensing limited - paracetamol codeine phosphate hemihydrate doxylamine succinate caffeine - tablets - 450/10/5/3 milligram

SYNDOL TABLETS אירלנד - אנגלית - HPRA (Health Products Regulatory Authority)

syndol tablets

seton products ltd - paracetamol codeine phosphate hemihydrate doxylamine succinate caffeine - tablets

Mersyndol Forte אוסטרליה - אנגלית - Department of Health (Therapeutic Goods Administration)

mersyndol forte

sanofi-aventis australia pty ltd - paracetamol; codeine phosphate; doxylamine succinate -

MERSYNDOL FORTE paracetamol 450 mg / codeine phosphate hemihydrate 30 mg / doxylamine succinate 5 mg tablet blister pack אוסטרליה - אנגלית - Department of Health (Therapeutic Goods Administration)

mersyndol forte paracetamol 450 mg / codeine phosphate hemihydrate 30 mg / doxylamine succinate 5 mg tablet blister pack

sanofi-aventis australia pty ltd - codeine phosphate hemihydrate, quantity: 30 mg; paracetamol, quantity: 450 mg; doxylamine succinate, quantity: 5 mg - tablet, uncoated - excipient ingredients: sodium starch glycollate; magnesium stearate; purified talc; stearic acid; povidone; pregelatinised maize starch; crospovidone - indications as at 9 june 2020: mersyndol forte is indicated for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain.

MEVADOL FORTE paracetamol 450 mg/ codeine phosphate hemihydrate 30 mg/ doxylamine succinate 5 mg tablet blister pack אוסטרליה - אנגלית - Department of Health (Therapeutic Goods Administration)

mevadol forte paracetamol 450 mg/ codeine phosphate hemihydrate 30 mg/ doxylamine succinate 5 mg tablet blister pack

arrotex pharmaceuticals pty ltd - paracetamol, quantity: 450 mg; codeine phosphate hemihydrate, quantity: 30 mg; doxylamine succinate, quantity: 5 mg - tablet, uncoated - excipient ingredients: purified talc; microcrystalline cellulose; magnesium stearate; sodium starch glycollate; hypromellose - mevadol forte is indicated for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain.